Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Obéric · SciRah

Researcher profile · Semantic Scholar

L. Obéric

Share profile

L. Obéric — researcher profile on SciRah

h-index: 29
Works: 184
Citations: 4,506

Most-cited papers

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
H. Tilly, F. Morschhauser, L. Sehn, J. Friedberg +28 more
2021New England Journal of Medicine735 citations Open access
Semantic Scholar
Management and outcome of primary CNS lymphoma in the modern era: An LOC network study.
C. Houillier, C. Soussain, H. Ghesquières, P. Soubeyran +54 more
2020Neurology197 citations Open access
Semantic Scholar
Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial
R. Houot, E. Bachy, G. Cartron, F. Gros +25 more
2023Nature Medicine102 citations Open access
Semantic Scholar
Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older.
L. Obéric, F. Peyrade, M. Puyade, C. Bonnet +21 more
2021Journal of Clinical Oncology65 citations Open access
Semantic Scholar
Real-World Experience Among Patients with Relapsed/Refractory Mantle Cell Lymphoma after Bruton Tyrosine Kinase Inhibitor Failure in Europe: the SCHOLAR-2 Retrospective Chart Review Study
G. Hess, M. Dreyling, L. Obéric, E. Giné +21 more
2022British Journal of Haematology52 citations Open access
Semantic Scholar
Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma
Victor Bobée, F. Drieux, V. Marchand, Vincent Sater +15 more
2020Blood Cancer Journal49 citations Open access
Semantic Scholar
Intravenous high‐dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study
M. Lam, V. Touitou, S. Choquet, N. Cassoux +42 more
2021American journal of hematology/oncology40 citations Open access
Semantic Scholar
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma
Franck Morschhauser, G. Salles, Laurie H. Sehn, Alex F. Herrera +33 more
2025Journal of Clinical Oncology37 citations Open access
Semantic Scholar
Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma
C. Rossi, M. Tosolini, P. Gravelle, S. Péricart +17 more
2020Haematologica32 citations Open access
Semantic Scholar
Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study
C. Sarkozy, C. Thieblemont, L. Obéric, Anne Moreau +17 more
2023Journal of Clinical Oncology26 citations
Semantic Scholar
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network
L. Schenone, C. Houillier, M. Tanguy, Sylvain Choquet +45 more
2022Bone Marrow Transplantation24 citations
Semantic Scholar
Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy
V. Camus, R. Houot, G. Brisou, B. Tessoulin +28 more
2024Blood Advances21 citations Open access
Semantic Scholar
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group.
S. le Gouill, A. Beldi-Ferchiou, M. Alcantara, V. Cacheux +21 more
2020The Lancet Haematology20 citations Open access
Semantic Scholar
A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort
H. Ghesquières, C. Rossi, F. Cherblanc, S. Leguyader-Peyrou +24 more
2021BMC Public Health19 citations Open access
Semantic Scholar
Population Pharmacokinetics of Ibrutinib and Its Dihydrodiol Metabolite in Patients with Lymphoid Malignancies
F. Gallais, L. Ysebaert, F. Despas, S. Barros +8 more
2020Clinical Pharmacokinetics18 citations
Semantic Scholar
Molecular diagnosis of T-cell lymphoma: a correlative study of PCR-based T-cell clonality assessment and targeted NGS
C. Syrykh, Pauline Gorez, S. Péricart, D. Grand +8 more
2021Blood Advances17 citations Open access
Semantic Scholar
Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial
B. Tessoulin, D. Chiron, C. Thieblemont, L. Obéric +17 more
2021Bone Marrow Transplantation15 citations Open access
Semantic Scholar
Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group
Yannick Le Bris, F. Magrangeas, A. Moreau, D. Chiron +16 more
2020Hematological Oncology15 citations
Semantic Scholar
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
C. Sarkozy, L. Chartier, V. Ribrag, R. Gressin +26 more
2025Blood Cancer Journal14 citations Open access
Semantic Scholar
Rituximab-Lenalidomide(R2) Maintenance Is Superior to Rituximab Maintenance after First Line Immunochemotherapy in Mantle Cell Lymphoma: Results of the MCL R2 Elderly Clinical Trial
V. Ribrag, V. Safar, H. Kluin-Nelemans, L. Obéric +20 more
2021Blood14 citations Open access
Semantic Scholar
Primary B-Cell lymphoma of the uterine cervix presenting with right ureter hydronephrosis: A case report
M. Del, M. Ángeles, C. Syrykh, C. Martínez-Gómez +4 more
2020Gynecologic Oncology Reports14 citations Open access
Semantic Scholar
Clinical presentation, outcome, and prognostic markers in patients with intravascular large B‐cell lymphoma, a lymphoma study association (LYSA) retrospective study
A. Bonnet, C. Bossard, Ludovic Gabellier, J. Rohmer +20 more
2022Cancer Medicine13 citations Open access
Semantic Scholar
Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma
G. Hess, M. Dreyling, L. Obéric, E. Giné +21 more
2023Leukemia and Lymphoma12 citations Open access
Semantic Scholar
Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial
V. Camus, A. Belot, L. Obéric, D. Sibon +14 more
2022Blood Advances12 citations Open access
Semantic Scholar
Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma: Long-Term Efficacy and Safety Results from a Phase 2 Study
Michael L. Wang, S. Rule, P. Zinzani, A. Goy +21 more
2020Blood12 citations
Semantic Scholar
Obinutuzumab versus Rituximab in transplant-eligible Mantle cell lymphoma patients.
C. Sarkozy, M. Callanan, C. Thieblemont, L. Obéric +18 more
2024Blood11 citations Open access
Semantic Scholar
Unveiling the Clinical and Imaging Signatures of Intravascular Lymphoma of the Central Nervous System: A Multicentric Cohort Study
Elodie Berthet, A. Guillonnet, C. Houillier, R. Ursu +15 more
2024Annals of Neurology11 citations
Semantic Scholar
Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients
M. Alcantara, M. Chevrier, F. Jardin, A. Schmitt +9 more
2024Journal of Hematology & Oncology11 citations Open access
Semantic Scholar
Axicabtagene Ciloleucel As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Primary Analysis of Alycante, a Phase 2 Lysa Study
R. Houot, E. Bachy, G. Cartron, F. Gros +15 more
2022Blood10 citations Open access
Semantic Scholar
Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years
M. Jullien, B. Tessoulin, H. Ghesquières, L. Obéric +20 more
2021Cancers9 citations Open access
Semantic Scholar
The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
H. Tilly, F. Morschhauser, L. Sehn, J. Friedberg +28 more
2021Blood9 citations Open access
Semantic Scholar
Prevention and Treatment of Acute Kidney Injury Associated with High-Dose Methotrexate
S. Faguer, Chloé Médrano, S. Tavitian, L. Obéric
2025Kidney3608 citations Open access
Semantic Scholar
Induction and Maintenance Therapy in Elderly Patients with Mantle Cell Lymphoma: Double-Randomized MCL R2 Elderly Clinical Trial By the European Mantle Cell Lymphoma Network
V. Ribrag, V. Safar, H. Kluin-Nelemans, L. Obéric +17 more
2023Blood8 citations Open access
Semantic Scholar
Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study
N. Younan, C. Soussain, S. Choquet, N. Cassoux +25 more
2022Hematological Oncology8 citations Open access
Semantic Scholar
CAR T-Cell Therapy for Refractory Posttransplantation Lymphoproliferative Disorder in a Kidney Transplant Patient
Pierre Guy, Olivier Marion, L. Obéric, Amandine Darres +3 more
2024Transplantation Direct7 citations Open access
Semantic Scholar
Efficacy of dupilumab in eosinophilic dermatosis of haematologic malignancy (EDHM) needs to be confirmed
V. Sibaud, Aurore Brun, N. Meyer, L. Obéric +2 more
2021Journal of the European Academy of Dermatology and Venereology7 citations
Semantic Scholar
Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma
V. Camus, T. Molina, Fabienne Desmots, P. Blanc-Durand +33 more
2025Blood Advances6 citations Open access
Semantic Scholar
Impact of Maintenance Arm on Prognostic Value of MRD after Induction Treatment in MCL R2 Elderly Trial , a Mantle Cell Lymphoma Network Study
M. Delfau, E. Macintyre, M. Callanan, C. Pott +12 more
2021Blood4 citations Open access
Semantic Scholar
Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials
V. Letailleur, I. Chaillol, F. Cherblanc, H. Ghesquières +13 more
2025Blood Cancer Journal3 citations Open access
Semantic Scholar
MYC Rearrangement Prediction from LYSA Whole Slide Images in Large B-cell Lymphoma: A Multi-centric Validation of Self-supervised Deep Learning Models.
C. Syrykh, Valentina Di Proietto, E. Brion, C. Copie-Bergman +12 more
2024Modern Pathology3 citations
Semantic Scholar
A Comparison of Overall Survival with Brexucabtagene Autoleucel (Brexu-cel) CAR T-Cell Therapy (ZUMA-2) and Standard of Care (SCHOLAR-2) in Patients with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor (BTKi)
G. Hess, M. Dreyling, L. Obéric, E. Giné +21 more
2022Blood3 citations Open access
Semantic Scholar
Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study
Domitille Costes-Tertrais, T. Hueso, T. Gastinne, C. Thieblemont +15 more
2022Bone Marrow Transplantation3 citations
Semantic Scholar
CNS relapse in DLBCL patients below 60 years treated with R-ACVBP, R-CHOEP, or R-CHOP: A joint analysis of LYSA and GLA/DSHNHL.
C. Thieblemont, B. Altmann, O. Casasnovas, F. Frontzek +15 more
20213 citations
Semantic Scholar
Health-related quality of life after second-line axi-cel in transplant-ineligible patients with large B-cell lymphoma
Emilie Charton, Amelie Anota, Emmanuel Bachy, G. Cartron +24 more
2026Blood Advances2 citations Open access
Semantic Scholar
[Update on marginal zone lymphoma classification, diagnosis and treatment in 2024].
L. Obéric, K. Bouabdallah, S. Carras, C. Thieblemont
2025Bulletin du Cancer2 citations
Semantic Scholar
PHASE 2 NIVO-ALCL STUDY OF NIVOLUMAB FOR RELAPSE/REFRACTORY ALK+ALCL, FOR PATIENTS WITH PROGRESSIVE DISEASE OR AS CONSOLIDATIVE IMMUNOTHERAPY AFTER COMPLETE REMISSION
C. Rigaud, N. Ibrahimi, D. Sibon, K. Nysom +20 more
2025Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis2 citations Open access
Semantic Scholar
Risk stratification of patients with diffuse large B-cell lymphoma using plasma NMR-based metabolomics at diagnosis
A. Montagne, G. Bertho, Thomas Papastergiou, L. Chartier +15 more
2025Blood Advances2 citations
Semantic Scholar
Outcomes of Primary Mediastinal B-Cell Lymphoma Patients Treated with a PET-Guided Strategy in the Randomized Phase 3 Gained Study Conducted By Lysa
V. Camus, T. Molina, Fabienne Desmots-Loyer, Amine Moslemi +33 more
2024Blood2 citations
Semantic Scholar
Senior-IPI: An Easily Applicable and Meaningful Prognostic Index for First-Line LBCL Patients Older Than 80 Years Treated with Age-Adapted Immunochemotherapy
S. Dubois, F. Cherblanc, A. Belot, L. Obéric +5 more
2024Blood2 citations
Semantic Scholar
Correction: Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients
M. Alcantara, M. Chevrier, F. Jardin, A. Schmitt +9 more
2024Journal of Hematology & Oncology2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Thieblemont×24
Invite
C. Thieblemont — researcher profile on SciRah
R. Houot×17
Invite
R. Houot — researcher profile on SciRah
S. le Gouill×16
Invite
S. le Gouill — researcher profile on SciRah
H. Ghesquières×15
Invite
H. Ghesquières — researcher profile on SciRah

×13

Invite

G. Damaj — researcher profile on SciRah

O. Casasnovas×13

Invite

O. Casasnovas — researcher profile on SciRah

K. Bouabdallah×12

Invite

K. Bouabdallah — researcher profile on SciRah

F. Morschhauser×11

Invite

F. Morschhauser — researcher profile on SciRah

L. Fornecker×11

Invite

L. Fornecker — researcher profile on SciRah

Invite

F. Jardin — researcher profile on SciRah

Invite

R. Gressin — researcher profile on SciRah

Invite

H. Tilly — researcher profile on SciRah